Stephen Connelly

3.8k total citations · 2 hit papers
40 papers, 2.9k citations indexed

About

Stephen Connelly is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Stephen Connelly has authored 40 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Physiology and 8 papers in Immunology. Recurrent topics in Stephen Connelly's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers) and Alzheimer's disease research and treatments (6 papers). Stephen Connelly is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers) and Alzheimer's disease research and treatments (6 papers). Stephen Connelly collaborates with scholars based in United States, United Kingdom and New Zealand. Stephen Connelly's co-authors include Jeffery W. Kelly, Ian A. Wilson, Steven M. Johnson, Evan T. Powers, Sungwook Choi, Colleen Fearns, R. Luke Wiseman, Christine Bulawa, Jeff Packman and Michael J. DeVit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Stephen Connelly

40 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A structural analysis of M protein in coronavirus assembly and morphology

2010 576 citations Benjamin W. Neuman, Gabriella Kiss et al. Journal of Structural Biology profile →
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

2012 572 citations Stephen Connelly, Evan T. Powers et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Connelly United States	20	1.9k	504	495	478	451	40	2.9k
Scott D. Larsen United States	37	1.8k 1.0×	333 0.7×	988 2.0×	365 0.8×	232 0.5×	102	3.6k
Hollis D. Showalter United States	31	1.8k 0.9×	287 0.6×	853 1.7×	368 0.8×	148 0.3×	89	3.1k
David K. Clawson United States	23	1.2k 0.6×	178 0.4×	489 1.0×	307 0.6×	235 0.5×	40	2.5k
Akane Kawamura United Kingdom	36	3.4k 1.8×	224 0.4×	415 0.8×	350 0.7×	115 0.3×	101	4.5k
Donna M. Huryn United States	28	1.8k 1.0×	457 0.9×	1.3k 2.5×	291 0.6×	239 0.5×	80	3.5k
Hing L. Sham United States	37	2.1k 1.1×	870 1.7×	2.0k 4.1×	558 1.2×	133 0.3×	134	4.6k
Johann Hofmann Austria	29	1.4k 0.7×	167 0.3×	596 1.2×	953 2.0×	108 0.2×	78	2.7k
Louis Malspeis United States	26	1.5k 0.8×	235 0.5×	438 0.9×	682 1.4×	84 0.2×	83	2.9k
Peter Charlton United Kingdom	34	2.7k 1.4×	346 0.7×	602 1.2×	2.1k 4.4×	69 0.2×	74	4.5k
H. Michael Petrassi United States	18	1.6k 0.8×	70 0.1×	304 0.6×	263 0.6×	831 1.8×	29	2.4k

Countries citing papers authored by Stephen Connelly

Since Specialization

Citations

This map shows the geographic impact of Stephen Connelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Connelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Connelly more than expected).

Fields of papers citing papers by Stephen Connelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Connelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Connelly. The network helps show where Stephen Connelly may publish in the future.

Co-authorship network of co-authors of Stephen Connelly

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Connelly. A scholar is included among the top collaborators of Stephen Connelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Connelly. Stephen Connelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koreth, John, Jerome Ritz, Leslie W. Chinn, et al.. (2021). Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease. Blood. 138(Supplement 1). 2891–2891. 2 indexed citations

Koziol‐White, Cynthia, Gaoyuan Cao, Vishal Parikh, et al.. (2020). CD6 is highly expressed in fatal asthma patients and may modulate bronchomotor tone. 320–320. 1 indexed citations

Mukherjee, Manali, Katherine Radford, Sole Gatto, et al.. (2020). CD6-ALCAM Pathway is Elevated in Patients with Severe Asthma. 5283–5283. 1 indexed citations

Ng, Cherie, Jeanette Ampudia, Robert J. Soiffer, Jerome Ritz, & Stephen Connelly. (2019). Itolizumab As a Potential Therapeutic for the Prevention and Treatment of Graft Vs Host Disease. Blood. 134(Supplement_1). 5603–5603. 4 indexed citations

Connelly, Stephen, D.E. Mortenson, Sungwook Choi, et al.. (2017). Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(15). 3441–3449. 6 indexed citations

Brimble, Margaret A., et al.. (2014). Iridium-Catalysed C–H Borylation Facilitates a Total Synthesis of the HRV 3C Protease Inhibitor (±)-Thysanone. Synlett. 25(4). 556–558. 6 indexed citations

Saha, Arindam, Stephen Connelly, Jingjing Jiang, et al.. (2014). Akt Phosphorylation and Regulation of Transketolase Is a Nodal Point for Amino Acid Control of Purine Synthesis. Molecular Cell. 55(2). 264–276. 75 indexed citations

Connelly, Stephen, Yu Wang, Lei Zhao, et al.. (2013). AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin. Proceedings of the National Academy of Sciences. 110(24). 9992–9997. 144 indexed citations

Connelly, Stephen, Jessica K. DeMartino, Dale L. Boger, & Ian A. Wilson. (2013). Biological and Structural Evaluation of 10R- and 10S-Methylthio-DDACTHF Reveals a New Role for Sulfur in Inhibition of Glycinamide Ribonucleotide Transformylase. Biochemistry. 52(30). 5133–5144. 7 indexed citations

10.

Furkert, Daniel P., et al.. (2013). Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone). Organic & Biomolecular Chemistry. 12(6). 905–912. 15 indexed citations

11.

Connelly, Stephen, Bo Young Kim, Sung Jean Park, et al.. (2013). Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors. Chemical Communications. 49(80). 9188–9188. 38 indexed citations

12.

Johnson, Steven M., Stephen Connelly, Colleen Fearns, Evan T. Powers, & Jeffery W. Kelly. (2012). The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug. Journal of Molecular Biology. 421(2-3). 185–203. 257 indexed citations

13.

Connelly, Stephen, Sungwook Choi, Steven M. Johnson, Jeffery W. Kelly, & Ian A. Wilson. (2010). Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Current Opinion in Structural Biology. 20(1). 54–62. 143 indexed citations

14.

Neuman, Benjamin W., Gabriella Kiss, Andreas H. Kunding, et al.. (2010). A structural analysis of M protein in coronavirus assembly and morphology. Journal of Structural Biology. 174(1). 11–22. 576 indexed citations breakdown →

15.

Choi, Sungwook, Natàlia Reixach, Stephen Connelly, et al.. (2009). A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity. Journal of the American Chemical Society. 132(4). 1359–1370. 63 indexed citations

16.

Wang, Wei, William Blackledge, Stephen Connelly, et al.. (2008). The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis. Journal of Biological Chemistry. 284(6). 3521–3528. 50 indexed citations

17.

Johnson, Steven M., Stephen Connelly, Ian A. Wilson, & Jeffery W. Kelly. (2008). Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies. Journal of Medicinal Chemistry. 51(20). 6348–6358. 63 indexed citations

18.

Connelly, Stephen, et al.. (2005). Synthesis and characterisation of a ligand that forms a stable tetrahedral intermediate in the active site of the Aureobacterium species (–)γ-lactamase. Organic & Biomolecular Chemistry. 3(18). 3260–3260. 9 indexed citations

19.

Gordon, Newton C. & Stephen Connelly. (2003). Management of head and neck infections in the immunocompromised patient. Oral and Maxillofacial Surgery Clinics of North America. 15(1). 103–110. 10 indexed citations

20.

Cabaud, H. Edward, G. WILBUR WESTIN, & Stephen Connelly. (1979). Tendon transfers in the paralytic hip.. Journal of Bone and Joint Surgery. 61(7). 1035–1041. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact